NCT03665896

Brief Summary

The VivaSight™-DLT is a new OLV (one lung ventilation) device that contains an embedded camera. Therefore, a potential advantage is the continuous assessment of DLT position through continuous monitoring of the camera. The embedded camera of VivaSight™-DLT is positioned at the tracheal opening of the double lumen tube. It allows for continuous monitoring of the carina and bronchial tube placement. The purpose of this study is to determine if a double lumen tube (DLT) with an embedded video camera, the VivaSight DLT, can be used in similar fashion to the standard double lumen tube with fiberoptic bronchoscopy. More specifically, the investigators would like to know the difference in time to optimal position in the left bronchus between the VivaSight DLT and the standard DLT with fiberoptic bronchoscopy. In addition, the investigators would like to know if the embedded camera on the VivaSight DLT provides a view that will allow for the optimum position of the DLT in the left bronchus.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2013

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2014

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

September 4, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 11, 2018

Completed
Last Updated

September 11, 2018

Status Verified

September 1, 2018

Enrollment Period

8 months

First QC Date

September 4, 2018

Last Update Submit

September 7, 2018

Conditions

Keywords

double-lumen endotracheal tubeVivaSight double-lumen tube

Outcome Measures

Primary Outcomes (1)

  • Intubation time

    We will compare the intubation time for the VivaSight double-lumen tube (DLT) with the intubation time for standard DLT.

    Within 5 minutes

Secondary Outcomes (1)

  • Picture reliability of the embedded camera of VivaSight double-lumen tube

    Within 10 hours

Study Arms (2)

VivaSight DLT group

ACTIVE COMPARATOR

Thoracic surgery patient is intubated with VivaSight double-lumen tube (intubation with VivaSight double-lumen tube). The intubation time, duration between the passage of the tube through the vocal cords and the confirmation of proper tube positioning by the embedded camera, is recorded. The tube position is reconfirmed by fiberoptic bronchoscopy.

Device: intubation with VivaSight double-lumen tubeProcedure: fiberoptic bronchoscopy

Standard DLT group

PLACEBO COMPARATOR

Thoracic surgery patient is intubated with standard double-lumen tube (intubation with standard double-lumen tube). The intubation time, duration between the passage of the tube through the vocal cords and the confirmation of proper tube positioning by fiberoptic bronchoscopy, is recorded.

Device: intubation with standard double-lumen tubeProcedure: fiberoptic bronchoscopy

Interventions

Standard DLT groupVivaSight DLT group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years of age
  • Adult patient undergoing scheduled thoracic surgery which requires double-lumen tube placement

You may not qualify if:

  • More than 90 years of age
  • Patients with emergency surgery
  • Prisoners
  • Patient who cannot provide their own consent
  • Patient refusal
  • Non-English speaking patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Intubation

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Study Officials

  • Javier H Campos, MD

    University of Iowa Hospitals & Clinics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

September 4, 2018

First Posted

September 11, 2018

Study Start

July 10, 2013

Primary Completion

March 21, 2014

Study Completion

March 21, 2014

Last Updated

September 11, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification will be shared with researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal. IPD will be available for sharing immediately after publication and ending 5 years following article publication.

Shared Documents
STUDY PROTOCOL
Time Frame
IPD will be available for sharing immediately after publication and ending 5 years following article publication.
Access Criteria
IPD will be accessible to researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal.